Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by Chopper1BigDogon Feb 16, 2021 11:43am
125 Views
Post# 32573582

Looks Like a good day

Looks Like a good day Mr. Rebeck was the person responsible for finding the startup money. He did well at that task and allowed LexaGene to perform the research necessary to commercialize a product. He was instrumental in getting the commercialization money and left the company with enough cash for 2021. Although his financial ways caused dilution of the stock price it worked out good for LexaGene. Dr. Regan put his brilliance in the MiQLab technology and design. He also has great business intelligence. He is Thankful for Mr. Rebeck's contribution but knows it is time to push the company forward with a growth strategy. Mr. Mastrocola will bring new financial knowledge to the team. His previous positions at Arthur Andersen and Ernst & Young shows that LexaGene will perform its business by the book and with utmost integrity. It looks like a good strategic move. Still Long and Proud holder of LXXGF!
<< Previous
Bullboard Posts
Next >>